6550--HEMOCHRON SIGNATURE ELITE REAGENTS BASE PLUS 4 OPTION YEARS
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
262-NETWORK CONTRACT OFFICE 22 (36C262)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36C26226Q0159
NAICS
325413 - In-Vitro Diagnostic Substance Manufacturing
Classification Code
6550
Additional Details
The Department of Veterans Affairs, through its Network Contract Office 22 (NCO 22), has issued a Combined Synopsis/Solicitation for the procurement of Hemochron Signature Elite Reagents Base, with provisions for four additional option years. This opportunity is identified under procurement number 36C26226Q0159 and is currently active, with responses due by December 17, 2025.
The primary objective of this procurement is to secure a reliable supply of in-vitro diagnostic reagents specifically designed for use with the Hemochron Signature Elite system. These reagents are essential for supporting clinical laboratory operations, enabling accurate and timely diagnostic testing for patient care. The scope of the contract encompasses the base year of reagent supply, with the potential for four subsequent option years, ensuring continuity and long-term support for the facility’s diagnostic needs.
The place of performance for this contract is Tucson, Arizona, indicating that the products and services will be delivered to or utilized within this location. The procurement is classified under NAICS code 325413, which pertains to In-Vitro Diagnostic Substance Manufacturing, and carries the Product Service Code 6550, denoting medical and surgical instruments, equipment, and supplies.
The contracting entity responsible for this solicitation is the 262-Network Contract Office 22, a federal office within the Department of Veterans Affairs. Interested parties should direct all inquiries and submissions to the designated primary contact, Rebecca Gaba, at [email protected].
This solicitation is posted on SAM.gov, with six attachments available for review, which likely contain detailed specifications, terms, and instructions for proposal submission. Contractors are encouraged to thoroughly examine these documents to ensure compliance with all requirements and to assess alignment with their capabilities.
Key considerations for prospective offerors include the multi-year nature of the contract, the specialized product requirements, and the federal procurement context. While the notice does not specify set-aside requirements or special considerations, contractors should review the attached documents for any additional eligibility criteria or instructions.
Overall, this opportunity represents a significant and stable requirement for in-vitro diagnostic reagents, supporting the ongoing healthcare mission of the VA in Tucson, Arizona. Contractors with experience in manufacturing or supplying diagnostic substances for clinical laboratory use are encouraged to evaluate this solicitation and consider submitting a response by the stated deadline.
Documents6